The Pituitary World News Podcast

In our second Live Talk session, Dr. Lewis Blevins discusses the normal ranges of endocrine lab tests and shares examples from his pituitary practice. Also,  our guest this week, Pat Gildroy, who manages the Diabetes Insipidus Facebook group, Got DI, joins us for a fascinating discussion about this condition.

In the first Pituitary World News LIVE TALK radio-style program, our guest Dr. Manish Aghi discusses the many facets of headaches and pituitary tumors. If you missed the live broadcast, here is the show's podcast. Tune in to LIVE TALK every Thursday from 3:00 pm PST - 6:00 pm EST for the opportunity to call in and participate in these live conversations with pituitary experts and stakeholders.

For more information on LIVE TALK and how to join the studio every week, visit pituitaryworldnews.org.

In this podcast oriented to physicians, Dr. Lewis Blevins talks about a case of a patient with a pituitary lesion called a hemangiopericytoma invasive in the right cavernous sinus. Although the content is technical, patients and other interested parties may find the discussion interesting.

In today's podcast directed to physicians, PWN co-founder Dr. Lewis Blevins discusses the drug Recorlev® (levoketoconazole) recently approved by the FDA to treat endogenous Cushing's Syndrome. While this podcast contains medical and technical terminology, we encourage patients to listen to it and discuss it with their physicians.

To launch the eighth season of the Pituitary World News podcast, we welcome to our microphones, Brandy. Brandy has quite a story to tell us about her battle with Cushing’s disease and her diagnosis. Brandy is an American Sign Language (ASL) professional interpreter and an accomplished artist, blogger, and musician.  We caught up with Brandy a few days before the Holidays to chat about her experiences in what proved to be a very interesting chat.

In this podcast directed to physicians, Dr. Lewis Blevins shares his vast experience of 30 years treating patients with central hypothyroidism.

In the last podcast in the series on the drugs available to manage hypercortisolism, Dr. Blevins discusses mifepristone, trade name Korlym®.  

This is the fourth podcast in a series of five on medications to treat Cushing’s disease.  Today Dr. Blevins discusses Pasireotide, trade names Signifor and Signifor LAR.

Our third podcast in the series is on osilodrostat (trade name Isturisa®), a drug approved by the FDA in the US and the European Medicines Agency (EMA) to treat hypercortisolism in patients who are not candidates for surgery or those that surgery did not work.  In this podcast, Dr. BLevins takes us inside his clinical practice to share his experiences with the drug.

The second podcast in our series on the medical management of hypercortisolism focuses on the drug metyrapone. Dr. Blevins discusses the drug uses, how it works, and its side effects. 

Coming up next, a discussion on the drug Isturiza® (osilodrostat).